Quoin Pharma Director Langer Dennis Buys 56,000+ Shares, Signals Confidence Amid Volatile Stock Price
Insider buy by Langer Dennis shows confidence in Quoin’s rare‑disease pipeline, yet the biotech’s low valuation and volatile market caution investors to watch upcoming milestones.
3 minutes to read